A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 2261
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : GD
Long Form : Graves' disease
No. Year Title Co-occurring Abbreviation
2022 2022 European Thyroid Association Guideline for the management of pediatric Graves' disease. ATD, RAI
2022 Aeromedical Decision Making for Military Aircrew with Graves' Disease. ATD, RAI, RSAF
2022 Elevated Levels of Circulating Biomarkers Related to Leaky Gut Syndrome and Bacterial Translocation Are Associated With Graves' Disease. DAO, I-FABP, LPS, QoL
2021 A cyclic peptide significantly improves thyroid function, thyrotropin-receptor antibodies and orbital mucine /collagen content in a long-term Graves' disease mouse model. Ab, Ad, TSHR
2021 A longitudinal study of medial temporal lobe volumes in Graves' disease. MR, MTL, TRAb
2021 A Meta-Analysis of Risk Factors for Transient and Permanent Hypocalcemia After Total Thyroidectomy. IPE, PA, PTH
2021 A Novel Long-Term Graves' Disease Animal Model Confirmed by Functional Thyrotropin Receptor Antibodies. SRR, TBII, TSHR-Ab
2021 A rapid homogenous bioassay for detection of thyroid-stimulating antibodies based on a luminescent cyclic AMP biosensor. AITD, G-PCR, TSHR
2021 Aberrant expression of inhibitory receptors on B cells in patients with Graves' disease. ELISA
10  2021 Advances in regulatory B cells in autoimmune thyroid diseases. AITD, HT
11  2021 Age Moderates the Impact of TRAbs on Thyroid Hormones and Hepatic Function in Patients with Graves' Disease. CI, HDF, OR, TRAbs
12  2021 Alemtuzumab-induced autoimmune thyroid events in patients with relapsing-remitting multiple sclerosis: A real-life and monocentric experience at a tertiary-level centre. AIATEs, RRMS, TRAb
13  2021 Alteration of the Intestinal Microbial Flora and the Serum IL-17 Level in Patients with Graves' Disease Complicated with Vitamin D Deficiency. NC
14  2021 Alterations of Gut Microbiota in Patients With Graves' Disease. ---
15  2021 Altered expression profile of BAFF receptors on peripheral blood B lymphocytes in Graves' disease. AITD, BR3, GO, HC, HT, TACI
16  2021 An early wave of macrophage infiltration intertwined with antigen specific proinflammatory T-cells and browning of adipose tissue characterizes the onset of orbital inflammation in a mouse model of Graves' orbitopathy. GO
17  2021 Antibodies against thyroid-stimulating hormone receptor cause maternal-neonatal transmission of Graves' Disease. Ab, TSHR
18  2021 Antioxidant Therapy in Graves' Orbitopathy. GO, ivGCs, ROS
19  2021 APPROACH TO THE PATIENT Fetal and neonatal thyroid dysfunction. CH, TRAb
20  2021 Association between Clinical Activity Score and Serum Interleukin-6, Interleukin-8 and Interleukin-10 during Systemic Glucocorticoid Treatment for Active Moderate-to-Severe Graves' Orbitopathy. CAS, GC, GO, HC, ILs
21  2021 Association of IL-1beta, NLRP3, and COX-2 Gene Polymorphisms with Autoimmune Thyroid Disease Risk and Clinical Features in the Iranian Population. HT
22  2021 Associations between gut microbiota and thyroidal function status in Chinese patients with Graves' disease. TRAb
23  2021 Autoimmune thyroid disease correlates to islet autoimmunity on zinc transporter 8 autoantibody. AITD, GADA, HC, HT, IA-2A, T1DM, TgAb, TPOAb, TRAb, ZnT8A
24  2021 Behavioral assessment of children and adolescents with Graves' disease: A prospective study. CBCL, TRAbs, TSH
25  2021 Blocking the Thyrotropin Receptor with K1-70 in a Patient with Follicular Thyroid Cancer, Graves' Disease, and Graves' Ophthalmopathy. FTC, GO, TSAb
26  2021 Case Report: A Rare Case of Coexisting of Autoimmune Polyglandular Syndrome Type 3 and Isolated Gonadotropin-Releasing Hormone Deficiency. APS, GnRH, LADA
27  2021 Celiac Disease and the Thyroid: Highlighting the Roles of Vitamin D and Iron. AITD, CD, HT, ID, TPO
28  2021 Changes in the Ocular Parameters of Patients with Graves' Disease after Antithyroid Drug Treatment. ATD, IOL
29  2021 Changes in Thyrotropin Receptor Antibody Levels Following Total Thyroidectomy or Radioiodine Therapy in Patients with Refractory Graves' Disease. ATDs, RAI, TBIIs
30  2021 Changes of autoantibodies and intercellular adhesion molecule-1 in patients with Graves disease after clinical treatment. ICAM-1, IGF-1, IL-17, IL-6, TPOAb, TSAb
31  2021 Characteristics of Patients with Type 1 Diabetes and Additional Autoimmune Disease in the DPV Registry. AD, AIDs, DPV, HT, T1DM
32  2021 Circulating Exosome Involves in the Pathogenesis of Autoimmune Thyroid Diseases Through Immunomodulatory Proteins. AITDs, DIA, HT, NC
33  2021 Clinical Characteristics and Prognosis of Coexisting Thyroid Cancer in Patients with Graves' Disease: A Retrospective Multicenter Study. LN
34  2021 Clinical Course of Euthyroid Subjects With Positive TSH Receptor Antibody: How Often Does Graves' Disease Develop? TRAb
35  2021 Clinical efficacy of thyroid-stimulating immunoglobulin detection for diagnosing Graves' disease and predictors of responsiveness to methimazole. AIT, GO, HS, ROC, TRAb, TSI
36  2021 Clinical relevance of estimating circulating interleukin-17 and interleukin-23 during methylprednisolone therapy in Graves' orbitopathy: A preliminary study. CAS, GO, IL-17, MP, TSHRAb
37  2021 Clinical Studies on Potassium Iodide-induced Painless Thyroiditis in 11 Graves' Disease Patients. ATD, PT, TgAb, TPOAb
38  2021 Compelling Evidence Linking CD40 Gene With Graves' Disease in the Chinese Han Population. GWAS, SNP
39  2021 Compositional and genetic alterations in Graves' disease gut microbiome reveal specific diagnostic biomarkers. MAGs
40  2021 Comprehensive Metabolomics Study in Children With Graves' Disease. HT, tRNA
41  2021 COVID-19 and Thyroid Diseases: A Bidirectional Impact. SARS-CoV-2, SAT
42  2021 Critical amino acid variants in HLA-DRB1 allotypes in the development of Graves' disease and Hashimoto's thyroiditis in the Japanese population. HLA, HT
43  2021 Cytokines as Targets of Novel Therapies for Graves' Ophthalmopathy. GO, IGF-1R, TSHR
44  2021 Decreased serum levels of IL-27and IL-35 in patients with Graves disease. ---
45  2021 Decreased Treg Cell and TCR Expansion Are Involved in Long-Lasting Graves' Disease. ATDs, nGD, pGD, TCR-seq
46  2021 Definitive treatment of Graves' disease in children and adolescents. ATDs, RAI, TT
47  2021 DES-Tcell is a knowledgebase for exploring immunology-related literature. HT, KB
48  2021 Determination of administered activities for the treatment of Graves' disease with iodine-131: Proposition of a simplified dosimetric procedure. ---
49  2021 Development of Graves' disease during drug-free remission of juvenile dermatomyositis. JDM, MTX, sIL-2R, TSH
50  2021 Diagnostic Utility of a New Assay for Thyroid Stimulating Immunoglobulins in Graves' Disease and Thyroid Eye Disease. OTS-TSI, TED, TSAbs
51  2021 Differentiation between thyroid-associated orbitopathy and Graves' disease by iTRAQ-based quantitative proteomic analysis. TAO
52  2021 Dipeptidyl peptidase-4 inhibitor might exacerbate Graves' disease: A multicenter observational case-control study. DPP-4, DPP-4i
53  2021 DNA hypermethylation of PTPN22 gene promoter in children and adolescents with Hashimoto thyroiditis. AITD, HT, PTPN22
54  2021 Does Age or Sex Relate to Severity or Treatment Prognosis in Graves' Disease? aHR, ATDs, CI, HR
55  2021 Drug-induced Grover's disease: a case report and review of the literature. DIGD
56  2021 Effects of glucocorticoid pulse therapy on thyroid function and thyroid antibodies in children with graves' disease. MPT, TgAb, TPOAb, TRAb
57  2021 Efficacy and adverse events related to the initial dose of methimazole in children and adolescents with Graves' disease. AEs, MMI
58  2021 Efficacy and safety of preoperative preparation with Lugol's iodine solution in euthyroid patients with Graves' disease (LIGRADIS Trial): Study protocol for a multicenter randomized trial. LS
59  2021 Establishment of a novel double-monoclonal antibody sandwich enzyme-linked immunosorbent assay (ELISA): tool for human B7-H4 detection in autoimmune diseases. ELISA, mAbs, sB7-H4, SLE
60  2021 Evaluating the Role of Circulating Dendritic Cells in Methimazole-Treated Pediatric Graves' Disease Patients. APCs, DCs
61  2021 Evaluation of analytic and clinical performance of two immunoassays for detecting thyroid-stimulating receptor antibody in the diagnosis of Graves' disease. NPV, PPV, ROC, TSHR, TSI
62  2021 Evaluation of choroidal circulation and stromal features in Graves' disease. CT, CVI, SA, TCA, TRAb
63  2021 Evaluation of interleukin-29 in autoimmune and inflammatory thyroid diseases. AUC, CI, CS, HT, IL-29, SAT
64  2021 Expansion of inflammatory monocytes in periphery and infiltrated into thyroid tissue in Graves' disease. TRAb
65  2021 Exposure to Propylthiouracil in the First Trimester of Pregnancy and Birth Defects: A Study at a Single Institution. PTU
66  2021 Favorable outcomes of papillary thyroid microcarcinoma concurrent with Graves' disease after radioactive iodine therapy. PTMC, RAI, TV-DR
67  2021 First case report of papillary thyroid carcinoma arising within a functional teratoma in Graves' disease patient. PTC
68  2021 Focus on radioiodine-131 biokinetics: the influence of methylprednisolone on intratherapeutic effective half-life of 131I during radioiodine therapy of Graves' disease. EHL, GO, RIT, RIUT
69  2021 Follow-up of infants born to mothers with Graves' disease. HN
70  2021 Free triiodothyronine to free thyroxine ratio in the differential diagnosis of thyrotoxicosis and hyperthyroidism: A retrospective study. DT, RAIU, TSH
71  2021 Glycosylation in Autoimmune Diseases. AITD, GnT-V, HT, IBD, IgG, MS, RA, SLE
72  2021 Glycosylation of Anti-Thyroglobulin IgG1 and IgG4 Subclasses in Thyroid Diseases. HT, IgG, PTC, PTC-T, TgAb
73  2021 Graves disease and metastatic hormonal-active Hurthle cell thyroid cancer: A case report. HCTC, RAI
74  2021 Graves' Disease and Rheumatoid Arthritis: A Bidirectional Mendelian Randomization Study. BBJ, GWAS, IVs, IVW, RA, SNPs
75  2021 Graves' disease associated with HIV disease and late immune reconstitution inflammatory syndrome following the initiation of antiretroviral therapy. ART, HIV
76  2021 Graves' Disease during Immune Checkpoint Inhibitor Therapy (A Case Series and Literature Review). ATD, ICPIs, TRAb
77  2021 Graves' disease in a five-month-old boy with an unusual treatment course. HPT, TH
78  2021 Graves' Disease in a Patient With Human Immunodeficiency Virus Infection as an Immune Reconstitution Inflammatory Syndrome. ART, HAART, HIV-1, IRIS
79  2021 Graves' disease patients with iron deficiency anemia: serologic evidence of co-existent autoimmune gastritis. H. pylori ab, IDA, PCab
80  2021 Graves' Disease Presenting as Autoimmune Hemolytic Anemia. AIHA
81  2021 Graves' Disease Presenting as Urticaria. ---
82  2021 Graves' disease with spontaneous resolution following ocrelizumab in primary progressive multiple sclerosis. IRT, TSH
83  2021 Graves' Orbitopathy: Report of 82 cases. GO, MRI
84  2021 Hashimoto's Thyroiditis and Graves' Disease in Genetic Syndromes in Pediatric Age. AITDs, HT
85  2021 Hemodynamic Instability during Thyroidectomy in Graves' Disease. ATDs, TRAb
86  2021 High Levels of Thyroid Hormone Impair Regulatory T Cell Function Via Reduced PD-1 Expression. PBMCs, PD-1
87  2021 How to use thionamide anti-thyroid drug in the young- what's new? ATD
88  2021 Hyperthyroidism in adolescents. RAIU, TSHR
89  2021 Hyperthyroidism Prevalence in China After Universal Salt Iodization. CI, DI, OR, USI
90  2021 Identification of lncRNA and mRNA Expression Profile in Relapsed Graves' Disease. WGCNA
91  2021 Identification of New Rare Variants Associated With Familial Autoimmune Thyroid Diseases by Deep Sequencing of Linked Loci. AITD, DLST, HT, IPMK, MetAP2, PGAM1P5
92  2021 Identification of Novel Environmental Substances Relevant to Pediatric Graves' Disease. ICP-MS, SNPs, UHPLC-MRM-MS
93  2021 Identification of Two Different Phenotypes of Patients with Amiodarone-Induced Thyrotoxicosis and Positive Thyrotropin Receptor Antibody Tests. AIT, CHO
94  2021 Identifying and Validating Differentially Methylated Regions in Newly Diagnosed Patients with Graves' Disease. DMRs, MeDIP, Pax5, PPI
95  2021 IgG4 as a Biomarker in Graves' Orbitopathy. CAS, GO, IgG4-RD
96  2021 Immune reconstitution inflammatory syndrome-associated Graves disease in HIV-infected patients: clinical characteristics and response to radioactive iodine therapy. IRIS-GD, RAI
97  2021 Immunotherapy with a biologically active ICAM-1 mAb and an siRNA targeting TSHR in a BALB/c mouse model of Graves' disease. EP, TSAb, TSBAb, TSH
98  2021 Impact of Graves Disease on Ocular Surface and Corneal Epithelial Thickness in Patients With and Without Graves Orbitopathy. CET, GO
99  2021 Incidence, risk factors, natural history and outcomes of heart failure in patients with Graves' disease. AF, BMI, HF, HFpEF, HFrEF, TRAb
100  2021 Inclusion of ALKBH5 as a candidate gene for the susceptibility of autoimmune thyroid disease. AITD, ALKBH5, HiSeq, HT, m6A, SNPs